Shanghai Shyndec Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of June 2025: 8.99%

Shanghai Shyndec Pharmaceutical Co Ltd asset resilience ratio. Shanghai Shyndec Pharmaceutical Co Ltd (600420) has an Asset Resilience Ratio of 8.99% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600420 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.77 Billion

≈ $258.60 Million USD Cash + Short-term Investments

Total Assets

CN¥19.67 Billion

≈ $2.88 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Shanghai Shyndec Pharmaceutical Co Ltd (2004–2024)

Asset resilience ratio of Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2024. This chart shows how Shanghai Shyndec Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 600420 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Shyndec Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shanghai Shyndec Pharmaceutical Co Ltd (600420) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.77 Billion	8.99%
Total Liquid Assets	CN¥1.77 Billion	8.99%

Asset Resilience Insights

Limited Liquidity: Shanghai Shyndec Pharmaceutical Co Ltd maintains only 8.99% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanghai Shyndec Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shanghai Shyndec Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Porton Fine Chemicals Ltd SHE:300363	Drug Manufacturers - Specialty & Generic	6.85%
Jubilant Pharmova Limited NSE:JUBLPHARMA	Drug Manufacturers - Specialty & Generic	1.26%

Shanghai Shyndec Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2004–2024)

Shanghai Shyndec Pharmaceutical Co Ltd asset resilience ratio by year from 2004 to 2024. The table below shows the annual Asset Resilience Ratio data for Shanghai Shyndec Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	7.17%	CN¥1.43 Billion ≈ $209.41 Million	CN¥19.96 Billion ≈ $2.92 Billion	+6.97pp
2018-12-31	0.20%	CN¥33.00 Million ≈ $4.83 Million	CN¥16.46 Billion ≈ $2.41 Billion	+0.07pp
2017-12-31	0.13%	CN¥20.00 Million ≈ $2.93 Million	CN¥15.17 Billion ≈ $2.22 Billion	-0.40pp
2016-12-31	0.53%	CN¥80.00 Million ≈ $11.71 Million	CN¥15.02 Billion ≈ $2.20 Billion	+0.29pp
2015-12-31	0.24%	CN¥10.00 Million ≈ $1.46 Million	CN¥4.14 Billion ≈ $605.43 Million	+0.19pp
2007-12-31	0.05%	CN¥371.52K ≈ $54.37K	CN¥713.86 Million ≈ $104.46 Million	-0.04pp
2004-12-31	0.09%	CN¥470.44K ≈ $68.84K	CN¥516.19 Million ≈ $75.54 Million	--

pp = percentage points

About Shanghai Shyndec Pharmaceutical Co Ltd

SHG:600420 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.63 Billion

CN¥11.12 Billion CNY

Market Cap Rank

#6670 Global

#1326 in China

Share Price

CN¥8.29

Change (1 day)

-0.84%

52-Week Range

CN¥7.78 - CN¥10.97

All Time High

CN¥17.27